Genetic association between functional haplotype of collagen type III alpha 1 and chronic hepatitis B and cirrhosis in Koreans

Tissue Antigens

Volumn 72, Issue 6, 2008, Pages 539-548

  Lee, S K ^a   Yi, C H ^a   Kim, M H ^a   Cheong, J Y ^b   Cho, S W ^b   Yang, S J ^c   Kwack, K ^a  

^a CHA University   (South Korea)

^b Ajou University School of Medicine   (South Korea)

^c Macrogen Inc   (South Korea)

Author keywords

Chronic hepatitis B; Collagen type III alpha 1; Liver cirrhosis; Single nucleotide polymorphism

Indexed keywords

COLLAGEN TYPE 3; COLLAGEN TYPE 3 ALPHA 1; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; CAUCASIAN; CHINESE; CHRONIC HEPATITIS; GENE CONSTRUCT; GENE LINKAGE DISEQUILIBRIUM; GENE LOCATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HEPATITIS B; HUMAN; HUMAN CELL; IN VITRO STUDY; INTRON; JAPANESE; KOREA; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTION REGULATION;

ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; COLLAGEN TYPE III; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HEPATITIS B, CHRONIC; HUMANS; KOREA; LINKAGE DISEQUILIBRIUM; LIVER CIRRHOSIS; POLYMORPHISM, SINGLE NUCLEOTIDE;

HEPATITIS B VIRUS;

EID: 55949090601     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2008.01144.x     Document Type: Article

References (36)

1. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003 : 362 : 1907 17.
2. Chen DS. Public health measures to control hepatitis B virus infection in the developing countries of the Asia-Pacific region. J Gastroenterol Hepatol 2000 : 15 (Suppl E7 10.
3. Arbuthnot P, Kew M. Hepatitis B virus and hepatocellular carcinoma. Int J Exp Pathol 2001 : 82 : 77 100.
4. Lee WM. Hepatitis B virus infection. N Engl J Med 1997 : 337 : 1733 45.
5. Bataller R, Brenner DA. Liver fibrosis. J Clin Invest 2005 : 115 : 209 18.
6. Friedman SL. Liver fibrosis - from bench to bedside. J Hepatol 2003 : 38 (Suppl 1 S38 53.
7. Misaki M, Shima T, Yano Y et al. Basement membrane-related and type III procollagen-related antigens in serum of patients with chronic viral liver disease. Clin Chem 1990 : 36 : 522 4.
8. Plebani M, Burlina A. Biochemical markers of hepatic fibrosis. Clin Biochem 1991 : 24 : 219 39.
9. Attallah AM, Mosa TE, Omran MM, Abo-Zeid MM, El-Dosoky I, Shaker YM. Immunodetection of collagen types I, II, III, and IV for differentiation of liver fibrosis stages in patients with chronic HCV. J Immunoassay Immunochem 2007 : 28 : 155 68.
10. Okamura N, Yoshida M, Shibuya A, Sugiura H, Okayasu I, Ohbu M. Cellular and stromal characteristics in the scirrhous hepatocellular carcinoma: comparison with hepatocellular carcinomas and intrahepatic cholangiocarcinomas. Pathol Int 2005 : 55 : 724 31.
11. Sakakibara K, Ooshima A, Igarashi S, Sakakibara J. Immunolocalization of type III collagen and procollagen in cirrhotic human liver using monoclonal antibodies. Virchows Arch A Pathol Anat Histopathol 1986 : 409 : 37 46.
12. Rojkind M, Martinez-Palomo A. Increase in type I and type III collagens in human alcoholic liver cirrhosis. Proc Natl Acad Sci U S A 1976 : 73 : 539 43.
13. Bruck R, Hershkoviz R, Lider O, Shirin H, Aeed H, Halpern Z. The use of synthetic analogues of Arg-Gly-Asp (RGD) and soluble receptor of tumor necrosis factor to prevent acute and chronic experimental liver injury. Yale J Biol Med 1997 : 70 : 391 402.
14. Jung MC, Pape GR. Immunology of hepatitis B infection. Lancet Infect Dis 2002 : 2 : 43 50.
15. Ahn SH, Han KH, Park JY et al. Association between hepatitis B virus infection and HLA-DR type in Korea. Hepatology 2000 : 31 : 1371 3.
16. Kim YJ, Lee HS, Yoon JH et al. Association of TNF-alpha promoter polymorphisms with the clearance of hepatitis B virus infection. Hum Mol Genet 2003 : 12 : 2541 6.
17. Goldstein DB, Ahmadi KR, Weale ME, Wood NW. Genome scans and candidate gene approaches in the study of common diseases and variable drug responses. Trends Genet 2003 : 19 : 615 22.
18. Tabor HK, Risch NJ, Myers RM. Candidate-gene approaches for studying complex genetic traits: practical considerations. Nat Rev Genet 2002 : 3 : 391 7.
19. Lewontin RC. The interaction of selection and linkage. I. General considerations; heterotic models. Genetics 1964 : 49 : 49 67.
20. Excoffier L, Slatkin M. Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol 1995 : 12 : 921 7.
21. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005 : 21 : 263 5.
22. InternationalHapMapConsortium. A haplotype map of the human genome. Nature 2005 : 437 : 1299 320.
23. Gabriel SB, Schaffner SF, Nguyen H et al. The structure of haplotype blocks in the human genome. Science 2002 : 296 : 2225 9.
24. Muckian C, Fitzgerald A, O'Neill A, O'Byrne A, Fitzgerald DJ, Shields DC. Genetic variability in the extracellular matrix as a determinant of cardiovascular risk: association of type III collagen COL3A1 polymorphisms with coronary artery disease. Blood 2002 : 100 : 1220 3.
25. Schwarze U, Schievink WI, Petty E et al. Haploinsufficiency for one COL3A1 allele of type III procollagen results in a phenotype similar to the vascular form of Ehlers-Danlos syndrome, Ehlers-Danlos syndrome type IV. Am J Hum Genet 2001 : 69 : 989 1001.
26. Dalgleish R. The Human Collagen Mutation Database 1998. Nucleic Acids Res 1998 : 26 : 253 5.
27. Kauppila S, Stenback F, Risteli J, Jukkola A, Risteli L. Aberrant type I and type III collagen gene expression in human breast cancer in vivo. J Pathol 1998 : 186 : 262 8.
28. Zhu GG, Risteli J, Puistola U, Kauppila A, Risteli L. Progressive ovarian carcinoma induces synthesis of type I and type III procollagens in the tumor tissue and peritoneal cavity. Cancer Res 1993 : 53 : 5028 32.
29. Jussila T, Kauppila S, Bode M et al. Synthesis and maturation of type I and type III collagens in endometrial adenocarcinoma. Eur J Obstet Gynecol Reprod Biol 2004 : 115 : 66 74.
30. Leonardi S, La Spina M, La Rosa M, Schiliro G. Prolylhydroxylase and procollagen type III in long-term survivors of acute lymphoblastic leukemia (ALL): a biochemical approach to HCV-related liver disease. Med Pediatr Oncol 2003 : 41 : 17 20.
31. Gressner OA, Weiskirchen R, Gressner AM. Biomarkers of liver fibrosis: clinical translation of molecular pathogenesis or based on liver-dependent malfunction tests. Clin Chim Acta 2007 : 381 : 107 13.
32. Giustina G, Fattovich G, De Paoli M et al. Serum procollagen type III peptide in chronic hepatitis B. Relationship to disease activity and response to interferon-alpha therapy. Int J Clin Lab Res 1996 : 26 : 33 6.
33. Pinzani M, Marra F. Cytokine receptors and signaling in hepatic stellate cells. Semin Liver Dis 2001 : 21 : 397 416.
34. Tsukamoto H. Cytokine regulation of hepatic stellate cells in liver fibrosis. Alcohol Clin Exp Res 1999 : 23 : 911 6.
35. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994 : 19 : 1513 20.
36. Park BK, Park YN, Ahn SH et al. Long-term outcome of chronic hepatitis B based on histological grade and stage. J Gastroenterol Hepatol 2007 : 22 : 383 8.